Peng L - Search Results

1

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.

Peng L, Hu Y, Mankowski MC, Ren P, Chen RE, Wei J, Zhao M, Li T, Tripler T, Ye L, Chow RD, Fang Z, Wu C, Dong MB, Cook M, Wang G, Clark P, Nelson B, Klein D, Sutton R, Diamond MS, Wilen CB, Xiong Y, Chen S. Peng L, et al. Nat Commun. 2022 Mar 28;13(1):1638. doi: 10.1038/s41467-022-29288-3. Nat Commun. 2022. PMID: 35347138 Free PMC article.

2

In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma.

Ye L, Park JJ, Dong MB, Yang Q, Chow RD, Peng L, Du Y, Guo J, Dai X, Wang G, Errami Y, Chen S. Ye L, et al. Among authors: peng l. Nat Biotechnol. 2019 Nov;37(11):1302-1313. doi: 10.1038/s41587-019-0246-4. Epub 2019 Sep 23. Nat Biotechnol. 2019. PMID: 31548728 Free PMC article.

3

Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.

Yuan S, Peng L, Park JJ, Hu Y, Devarkar SC, Dong MB, Shen Q, Wu S, Chen S, Lomakin IB, Xiong Y. Yuan S, et al. Among authors: peng l. Mol Cell. 2020 Dec 17;80(6):1055-1066.e6. doi: 10.1016/j.molcel.2020.10.034. Epub 2020 Oct 29. Mol Cell. 2020. PMID: 33188728 Free PMC article.

4

High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.

Chen JS, Chow RD, Song E, Mao T, Israelow B, Kamath K, Bozekowski J, Haynes WA, Filler RB, Menasche BL, Wei J, Alfajaro MM, Song W, Peng L, Carter L, Weinstein JS, Gowthaman U, Chen S, Craft J, Shon JC, Iwasaki A, Wilen CB, Eisenbarth SC. Chen JS, et al. Among authors: peng l. Sci Immunol. 2022 Feb 4;7(68):eabl5652. doi: 10.1126/sciimmunol.abl5652. Epub 2022 Feb 4. Sci Immunol. 2022. PMID: 34914544 Free PMC article.

5

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy.

Ye L, Park JJ, Peng L, Yang Q, Chow RD, Dong MB, Lam SZ, Guo J, Tang E, Zhang Y, Wang G, Dai X, Du Y, Kim HR, Cao H, Errami Y, Clark P, Bersenev A, Montgomery RR, Chen S. Ye L, et al. Among authors: peng l. Cell Metab. 2022 Apr 5;34(4):595-614.e14. doi: 10.1016/j.cmet.2022.02.009. Epub 2022 Mar 10. Cell Metab. 2022. PMID: 35276062 Free PMC article.

6

Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2.

Peng L, Renauer PA, Ökten A, Fang Z, Park JJ, Zhou X, Lin Q, Dong MB, Filler R, Xiong Q, Clark P, Lin C, Wilen CB, Chen S. Peng L, et al. Cell Rep Med. 2022 May 17;3(5):100634. doi: 10.1016/j.xcrm.2022.100634. Epub 2022 Apr 26. Cell Rep Med. 2022. PMID: 35561673 Free PMC article.

7

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2.

Fang Z, Peng L, Filler R, Suzuki K, McNamara A, Lin Q, Renauer PA, Yang L, Menasche B, Sanchez A, Ren P, Xiong Q, Strine M, Clark P, Lin C, Ko AI, Grubaugh ND, Wilen CB, Chen S. Fang Z, et al. Among authors: peng l. Nat Commun. 2022 Jun 6;13(1):3250. doi: 10.1038/s41467-022-30878-4. Nat Commun. 2022. PMID: 35668119 Free PMC article.

8

Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2.

Ssenyange G, Kerfoot M, Zhao M, Farhadian S, Chen S, Peng L, Ren P, Dela Cruz CS, Gupta S, Sutton RE. Ssenyange G, et al. Among authors: peng l. Cell Rep Methods. 2022 Jul 18;2(7):100252. doi: 10.1016/j.crmeth.2022.100252. Epub 2022 Jun 20. Cell Rep Methods. 2022. PMID: 35757815 Free PMC article.

9

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2.

Fang Z, Peng L, Lucas C, Lin Q, Zhou L, Yang L, Feng Y, Ren P, Renauer PA, Monteiro VS, Hahn AM, Park JJ, Zhou X; Yale SARS-CoV-2 Genomic Surveillance Initiative; Grubaugh ND, Wilen CB, Chen S. Fang Z, et al. Among authors: peng l. Cell Discov. 2022 Jul 19;8(1):69. doi: 10.1038/s41421-022-00435-w. Cell Discov. 2022. PMID: 35853867 Free PMC article. No abstract available.

10

Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species.

Peng L, Fang Z, Renauer PA, McNamara A, Park JJ, Lin Q, Zhou X, Dong MB, Zhu B, Zhao H, Wilen CB, Chen S. Peng L, et al. Cell Rep. 2022 Aug 2;40(5):111160. doi: 10.1016/j.celrep.2022.111160. Epub 2022 Jul 19. Cell Rep. 2022. PMID: 35921835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,117 results

Search Page

Filters